Breakthrough Chemistry Inc. (OTC: BKTH) Executes MOU to Acquire Kane & McHenry Enterprises LLC, DBA cellhelmet as Wholly Owned SubsidiaryHome THIS IS REAL NEWS, MANAGEMENT ARE DOING THE RIGHT THING
The good news for now is the fact that the company is actually moving forward with real revenues.
What shareholders should now be asking is, why did Cellhelmet sell their company BKTH? Think about it, they have a company that is currently forecast to do $9M in sales. From the 2023 PR, the contract was set at $5M over 5-years. Why I can understand why BKTH would do this deal, I find it more than interesting why Cellhelmet signed this MOU. Just thinking out loud.